Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)

7.58
Delayed Data
As of Jan 20
 -0.38 / -4.77%
Today’s Change
7.55
Today|||52-Week Range
43.26
-24.05%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 23.50, with a high estimate of 50.00 and a low estimate of 14.00. The median estimate represents a +210.03% increase from the last price of 7.58.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.91
Sales
$1.7M
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.61%
 
 
 
 
 
 
Growthannually 52.80%
 
 
 
 
 
 

Sales

Growthquarterly 61.33%
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
Key to the earnings and sales forecast charts.